Jci_page_head_homepage_01 Jci_page_head_homepage_02
Noriaki Okamoto, Risa Chihara, Chiori Shimizu, Sogo Nishimoto, Takeshi Watanabe
Published in Volume 117, Issue 4
J Clin Invest. 2007; 117(4):997–1007 doi:10.1172/JCI30379
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
Enrichment of memory-type (CD44hiCD62Llo) CD4+ T cells in aLNs or spleens of aLN-transplanted SCID mice.

(A) FACS plots demonstrating an increase in the CD44hiCD62Llo memory-type CD4+ T cell population in aLNs compared with that in lymph nodes of recipient BALB/c mice. Downward pointing arrows indicate the CD44/CD62L profile of cells within the CD4+ T cell gate. (B) FACS plots demonstrating an increase in the CD44hiCD62Llo memory-type CD4+ T cell population in the spleens of aLN-transplanted SCID mice, regardless of antigen stimulation, compared with that of lymph nodes or spleens in normal BALB/c mouse preimmunized with the same doses of NP-OVA. Numbers in the plots in A and B indicate the percentage of cells within the CD62Llo/CD44+ gate. (C) Immunohistochemical staining of CD127+ T cells in aLNs. Three weeks after aLNs were formed in NP-OVA preimmunized BALB/c mice, aLNs and lymph nodes of recipient BALB/c mice were stained with FITC-labeled anti-mouse CD3, anti-mouse CD127 antibodies, and Alexa Fluor 594–conjugated anti-rat IgG. Most CD3+ T cells were also CD127+.